...
首页> 外文期刊>International Journal of Pharmacy and Pharmaceutical Sciences >ANTIDIABETIC ACTIVITY AND ANTI-OXIDANT ACTIVITY OF NIDDWIN, A POLYHERBAL FORMULATION IN ALLOXAN INDUCED DIABETIC RATS
【24h】

ANTIDIABETIC ACTIVITY AND ANTI-OXIDANT ACTIVITY OF NIDDWIN, A POLYHERBAL FORMULATION IN ALLOXAN INDUCED DIABETIC RATS

机译:异养草诱导的糖尿病大鼠中多酚制剂尼德温的抗糖尿病活性和抗氧化剂活性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: The present study was focused to evaluate the antidiabetic activity and antioxidant activity of NIDDWI N, a polyherbal formulation in alloxan induced diabetic rats. Methods: Alloxan induced diabetic rats were divided into four groups of five each. Group-I was given aqueous suspension of 2% gum acacia, Group-II and III was given aqueous suspension of NIDDWIN 50mg/kg and 100mg/kg, Group-IV was given aqueous suspension of Glibenclamide 10mg/kg were given orally for 10days. The blood samples were collected before and after administration of drugs at 0, 2, 4, 6, and 8hrs on 1st, 5th, and 10thday from retro-orbital sinus, serum was separated and estimated for glucose, cholesterol and triglycerides levels. On 10thday pancreas were isolated from all the groups and subjected for histopathological studies. Diabetic rats were evaluated for anti-oxidant activity by using NIDDWIN. Results: NIDDWIN showed significant antidiabetic activity at 4thhr on 1st, 5thand 10thday was found to be effect in comparable with standard Glibenclamide 10mg/kg. Histopathological results of NIDDWIN showed positive results when compared with standard Glibenclamide 10mg/kg. NIDDWIN significantly showed the percentage reduction of lipid per-oxidation levels in diabetic rats. Conclusion: NIDDWIN a polyherbal formulation concluded that it possesses antidiabetic activity and anti-oxidant activity in diabetic rats and further NIDDWIN should be evaluated to develop probable mechanism of action
机译:目的:本研究的重点是评估多草药制剂NIDDWI N在四氧嘧啶诱导的糖尿病大鼠中的抗糖尿病活性和抗氧化活性。方法:将四氧嘧啶诱导的糖尿病大鼠分为四组,每组五只。给第一组口服给予2%胶状阿拉伯胶的水悬浮液,向第二组和第三组口服给予NIDDWIN 50mg / kg和100mg / kg的水性悬浮液,向第四组口服给予格列本脲10mg / kg的水性悬浮液,持续10天。在眼眶后窦第1、5、10天第0、2、4、6和8小时给药之前和之后采集血样,分离血清并评估其葡萄糖,胆固醇和甘油三酸酯水平。在第10天,从所有组中分离出胰腺,并进行组织病理学研究。使用NIDDWIN评估糖尿病大鼠的抗氧化活性。结果:NIDDWIN在第1、5和10天的第4小时显示出显着的抗糖尿病活性,与标准的格列本脲10mg / kg相当。与标准格列本脲10mg / kg相比,NIDDWIN的组织病理学结果显示阳性结果。 NIDDWIN显着显示糖尿病大鼠脂质过氧化水平降低的百分比。结论:NIDDWIN是一种多草药制剂,其结论是它在糖尿病大鼠中具有抗糖尿病活性和抗氧化活性,应进一步评估NIDDWIN以开发可能的作用机制

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号